Managing API raw material variability during continuous twin-screw wet granulation

[Display omitted] Very few studies have investigated the impact of raw material variability upon the granule critical quality attributes (CQAs) produced via twin-screw wet granulation (i.e., granule size distribution, density, flowability). In this study, the impact of the raw material variability o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutics 2019-04, Vol.561, p.265-273
Hauptverfasser: Stauffer, F., Vanhoorne, V., Pilcer, G., Chavez, Pierre-François, Vervaet, C., De Beer, T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 273
container_issue
container_start_page 265
container_title International journal of pharmaceutics
container_volume 561
creator Stauffer, F.
Vanhoorne, V.
Pilcer, G.
Chavez, Pierre-François
Vervaet, C.
De Beer, T.
description [Display omitted] Very few studies have investigated the impact of raw material variability upon the granule critical quality attributes (CQAs) produced via twin-screw wet granulation (i.e., granule size distribution, density, flowability). In this study, the impact of the raw material variability of an active pharmaceutical ingredient (API) in a high dose formulation on the twin-screw wet granulation process and on the resulting granule quality attributes was investigated. In a previous study (Stauffer et al., 2018), eight API batches were characterized to determine the API batch-to-batch variability. Principal component analysis (PCA) was then used to analyse the raw material property differences between the API batches and to determine the causes of the batch-to-batch variability. In current study, the three principal components from that PCA model were used as factors together with twin-screw granulation process parameters (i.e., screw speed and liquid-to-solid ratio) in a D-optimal screening design of experiments to understand the influence of these factors upon the granule CQAs. It was found that the API particle size distribution and related properties (e.g., density, agglomeration profile) were critical for the granule CQAs. In a next step, the significant factors from the screening design results were used to determine the design space of the twin-screw granulation process for the studied formulation via a D-optimal optimisation design, herewith controlling the risk of failure for the potential API raw material variability. The possibility to obtain suitable granule CQAs with a risk of failure of 1% for all API batches was demonstrated. It was thus possible to identify a combination of process parameters that can manage the API batch-to-batch variability leading to granules with pre-defined suitable CQAs.
doi_str_mv 10.1016/j.ijpharm.2019.03.012
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2189541613</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517319301905</els_id><sourcerecordid>2189541613</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-e17eb671545c15069d92cbdde7874dfaa0d1cbe42fbb44954a753d033395cec83</originalsourceid><addsrcrecordid>eNqFkMtOwzAQRS0EglL4BFCWbBI8cRwnK4QQj0ogEIK15djT4ipxiu1Q8fekamHLajbnzp05hJwBzYBCebnM7HL1oXyX5RTqjLKMQr5HJlAJlrJClPtkQpmoUg6CHZHjEJaU0jIHdkiOGK04sEpMyOuTcmph3SK5fpklXq2TTkX0VrXJlxpHY1sbvxMz-A2jexetG_ohJHFtXRq0x3WyxpgsvHJDq6Lt3Qk5mKs24OluTsn73e3bzUP6-Hw_u7l-TDUreUwRBDalAF5wDZyWtalz3RiDohKFmStFDegGi3zeNEVR80IJzgxljNVco67YlFxs9658_zlgiLKzQWPbKofjhTKHakxBCWxE-RbVvg_B41yuvO2U_5ZA5UanXMqdTrnRKSmTo84xd76rGJoOzV_q198IXG0BHB_9suhl0BadRmM96ihNb_-p-AFKf4of</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2189541613</pqid></control><display><type>article</type><title>Managing API raw material variability during continuous twin-screw wet granulation</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Stauffer, F. ; Vanhoorne, V. ; Pilcer, G. ; Chavez, Pierre-François ; Vervaet, C. ; De Beer, T.</creator><creatorcontrib>Stauffer, F. ; Vanhoorne, V. ; Pilcer, G. ; Chavez, Pierre-François ; Vervaet, C. ; De Beer, T.</creatorcontrib><description>[Display omitted] Very few studies have investigated the impact of raw material variability upon the granule critical quality attributes (CQAs) produced via twin-screw wet granulation (i.e., granule size distribution, density, flowability). In this study, the impact of the raw material variability of an active pharmaceutical ingredient (API) in a high dose formulation on the twin-screw wet granulation process and on the resulting granule quality attributes was investigated. In a previous study (Stauffer et al., 2018), eight API batches were characterized to determine the API batch-to-batch variability. Principal component analysis (PCA) was then used to analyse the raw material property differences between the API batches and to determine the causes of the batch-to-batch variability. In current study, the three principal components from that PCA model were used as factors together with twin-screw granulation process parameters (i.e., screw speed and liquid-to-solid ratio) in a D-optimal screening design of experiments to understand the influence of these factors upon the granule CQAs. It was found that the API particle size distribution and related properties (e.g., density, agglomeration profile) were critical for the granule CQAs. In a next step, the significant factors from the screening design results were used to determine the design space of the twin-screw granulation process for the studied formulation via a D-optimal optimisation design, herewith controlling the risk of failure for the potential API raw material variability. The possibility to obtain suitable granule CQAs with a risk of failure of 1% for all API batches was demonstrated. It was thus possible to identify a combination of process parameters that can manage the API batch-to-batch variability leading to granules with pre-defined suitable CQAs.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2019.03.012</identifier><identifier>PMID: 30851387</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Continuous manufacturing ; Managing active pharmaceutical ingredient variability ; Material properties ; Multivariate data analysis ; Quality by design ; Twin-screw granulation</subject><ispartof>International journal of pharmaceutics, 2019-04, Vol.561, p.265-273</ispartof><rights>2019 Elsevier B.V.</rights><rights>Copyright © 2019 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-e17eb671545c15069d92cbdde7874dfaa0d1cbe42fbb44954a753d033395cec83</citedby><cites>FETCH-LOGICAL-c365t-e17eb671545c15069d92cbdde7874dfaa0d1cbe42fbb44954a753d033395cec83</cites><orcidid>0000-0002-0040-1627 ; 0000-0003-4249-3408</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0378517319301905$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30851387$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stauffer, F.</creatorcontrib><creatorcontrib>Vanhoorne, V.</creatorcontrib><creatorcontrib>Pilcer, G.</creatorcontrib><creatorcontrib>Chavez, Pierre-François</creatorcontrib><creatorcontrib>Vervaet, C.</creatorcontrib><creatorcontrib>De Beer, T.</creatorcontrib><title>Managing API raw material variability during continuous twin-screw wet granulation</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>[Display omitted] Very few studies have investigated the impact of raw material variability upon the granule critical quality attributes (CQAs) produced via twin-screw wet granulation (i.e., granule size distribution, density, flowability). In this study, the impact of the raw material variability of an active pharmaceutical ingredient (API) in a high dose formulation on the twin-screw wet granulation process and on the resulting granule quality attributes was investigated. In a previous study (Stauffer et al., 2018), eight API batches were characterized to determine the API batch-to-batch variability. Principal component analysis (PCA) was then used to analyse the raw material property differences between the API batches and to determine the causes of the batch-to-batch variability. In current study, the three principal components from that PCA model were used as factors together with twin-screw granulation process parameters (i.e., screw speed and liquid-to-solid ratio) in a D-optimal screening design of experiments to understand the influence of these factors upon the granule CQAs. It was found that the API particle size distribution and related properties (e.g., density, agglomeration profile) were critical for the granule CQAs. In a next step, the significant factors from the screening design results were used to determine the design space of the twin-screw granulation process for the studied formulation via a D-optimal optimisation design, herewith controlling the risk of failure for the potential API raw material variability. The possibility to obtain suitable granule CQAs with a risk of failure of 1% for all API batches was demonstrated. It was thus possible to identify a combination of process parameters that can manage the API batch-to-batch variability leading to granules with pre-defined suitable CQAs.</description><subject>Continuous manufacturing</subject><subject>Managing active pharmaceutical ingredient variability</subject><subject>Material properties</subject><subject>Multivariate data analysis</subject><subject>Quality by design</subject><subject>Twin-screw granulation</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqFkMtOwzAQRS0EglL4BFCWbBI8cRwnK4QQj0ogEIK15djT4ipxiu1Q8fekamHLajbnzp05hJwBzYBCebnM7HL1oXyX5RTqjLKMQr5HJlAJlrJClPtkQpmoUg6CHZHjEJaU0jIHdkiOGK04sEpMyOuTcmph3SK5fpklXq2TTkX0VrXJlxpHY1sbvxMz-A2jexetG_ohJHFtXRq0x3WyxpgsvHJDq6Lt3Qk5mKs24OluTsn73e3bzUP6-Hw_u7l-TDUreUwRBDalAF5wDZyWtalz3RiDohKFmStFDegGi3zeNEVR80IJzgxljNVco67YlFxs9658_zlgiLKzQWPbKofjhTKHakxBCWxE-RbVvg_B41yuvO2U_5ZA5UanXMqdTrnRKSmTo84xd76rGJoOzV_q198IXG0BHB_9suhl0BadRmM96ihNb_-p-AFKf4of</recordid><startdate>20190420</startdate><enddate>20190420</enddate><creator>Stauffer, F.</creator><creator>Vanhoorne, V.</creator><creator>Pilcer, G.</creator><creator>Chavez, Pierre-François</creator><creator>Vervaet, C.</creator><creator>De Beer, T.</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0040-1627</orcidid><orcidid>https://orcid.org/0000-0003-4249-3408</orcidid></search><sort><creationdate>20190420</creationdate><title>Managing API raw material variability during continuous twin-screw wet granulation</title><author>Stauffer, F. ; Vanhoorne, V. ; Pilcer, G. ; Chavez, Pierre-François ; Vervaet, C. ; De Beer, T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-e17eb671545c15069d92cbdde7874dfaa0d1cbe42fbb44954a753d033395cec83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Continuous manufacturing</topic><topic>Managing active pharmaceutical ingredient variability</topic><topic>Material properties</topic><topic>Multivariate data analysis</topic><topic>Quality by design</topic><topic>Twin-screw granulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stauffer, F.</creatorcontrib><creatorcontrib>Vanhoorne, V.</creatorcontrib><creatorcontrib>Pilcer, G.</creatorcontrib><creatorcontrib>Chavez, Pierre-François</creatorcontrib><creatorcontrib>Vervaet, C.</creatorcontrib><creatorcontrib>De Beer, T.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stauffer, F.</au><au>Vanhoorne, V.</au><au>Pilcer, G.</au><au>Chavez, Pierre-François</au><au>Vervaet, C.</au><au>De Beer, T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Managing API raw material variability during continuous twin-screw wet granulation</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2019-04-20</date><risdate>2019</risdate><volume>561</volume><spage>265</spage><epage>273</epage><pages>265-273</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><abstract>[Display omitted] Very few studies have investigated the impact of raw material variability upon the granule critical quality attributes (CQAs) produced via twin-screw wet granulation (i.e., granule size distribution, density, flowability). In this study, the impact of the raw material variability of an active pharmaceutical ingredient (API) in a high dose formulation on the twin-screw wet granulation process and on the resulting granule quality attributes was investigated. In a previous study (Stauffer et al., 2018), eight API batches were characterized to determine the API batch-to-batch variability. Principal component analysis (PCA) was then used to analyse the raw material property differences between the API batches and to determine the causes of the batch-to-batch variability. In current study, the three principal components from that PCA model were used as factors together with twin-screw granulation process parameters (i.e., screw speed and liquid-to-solid ratio) in a D-optimal screening design of experiments to understand the influence of these factors upon the granule CQAs. It was found that the API particle size distribution and related properties (e.g., density, agglomeration profile) were critical for the granule CQAs. In a next step, the significant factors from the screening design results were used to determine the design space of the twin-screw granulation process for the studied formulation via a D-optimal optimisation design, herewith controlling the risk of failure for the potential API raw material variability. The possibility to obtain suitable granule CQAs with a risk of failure of 1% for all API batches was demonstrated. It was thus possible to identify a combination of process parameters that can manage the API batch-to-batch variability leading to granules with pre-defined suitable CQAs.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>30851387</pmid><doi>10.1016/j.ijpharm.2019.03.012</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-0040-1627</orcidid><orcidid>https://orcid.org/0000-0003-4249-3408</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2019-04, Vol.561, p.265-273
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_2189541613
source Elsevier ScienceDirect Journals Complete
subjects Continuous manufacturing
Managing active pharmaceutical ingredient variability
Material properties
Multivariate data analysis
Quality by design
Twin-screw granulation
title Managing API raw material variability during continuous twin-screw wet granulation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T10%3A18%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Managing%20API%20raw%20material%20variability%20during%20continuous%20twin-screw%20wet%20granulation&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Stauffer,%20F.&rft.date=2019-04-20&rft.volume=561&rft.spage=265&rft.epage=273&rft.pages=265-273&rft.issn=0378-5173&rft.eissn=1873-3476&rft_id=info:doi/10.1016/j.ijpharm.2019.03.012&rft_dat=%3Cproquest_cross%3E2189541613%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2189541613&rft_id=info:pmid/30851387&rft_els_id=S0378517319301905&rfr_iscdi=true